Medpace Holdings, Inc. (NASDAQ:MEDP) Shares Bought by Larson Financial Group LLC

Larson Financial Group LLC raised its stake in Medpace Holdings, Inc. (NASDAQ:MEDP - Free Report) by 9.0% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 9,509 shares of the company's stock after purchasing an additional 788 shares during the quarter. Larson Financial Group LLC's holdings in Medpace were worth $3,159,000 at the end of the most recent quarter.

Several other institutional investors also recently made changes to their positions in MEDP. Centaurus Financial Inc. raised its position in shares of Medpace by 2.0% in the 3rd quarter. Centaurus Financial Inc. now owns 1,513 shares of the company's stock worth $505,000 after buying an additional 29 shares during the period. Lindbrook Capital LLC increased its stake in Medpace by 27.6% during the fourth quarter. Lindbrook Capital LLC now owns 134 shares of the company's stock worth $45,000 after acquiring an additional 29 shares during the last quarter. Assetmark Inc. raised its holdings in shares of Medpace by 20.1% in the 4th quarter. Assetmark Inc. now owns 173 shares of the company's stock worth $57,000 after purchasing an additional 29 shares during the period. Proficio Capital Partners LLC lifted its stake in shares of Medpace by 4.1% in the 4th quarter. Proficio Capital Partners LLC now owns 730 shares of the company's stock valued at $243,000 after purchasing an additional 29 shares in the last quarter. Finally, Schulhoff & Co. Inc. grew its holdings in shares of Medpace by 1.2% during the 4th quarter. Schulhoff & Co. Inc. now owns 2,630 shares of the company's stock worth $874,000 after purchasing an additional 30 shares during the period. 77.98% of the stock is owned by hedge funds and other institutional investors.

Remove Ads

Medpace Trading Up 2.2 %

NASDAQ:MEDP traded up $7.08 during trading hours on Friday, hitting $332.81. The stock had a trading volume of 369,897 shares, compared to its average volume of 302,398. The business has a 50 day simple moving average of $341.10 and a two-hundred day simple moving average of $342.93. Medpace Holdings, Inc. has a 1-year low of $302.01 and a 1-year high of $459.77. The company has a market cap of $10.14 billion, a PE ratio of 26.35, a price-to-earnings-growth ratio of 3.81 and a beta of 1.47.

Medpace (NASDAQ:MEDP - Get Free Report) last released its quarterly earnings results on Monday, February 10th. The company reported $3.67 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.96 by $0.71. Medpace had a net margin of 19.17% and a return on equity of 51.48%. Research analysts expect that Medpace Holdings, Inc. will post 12.29 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Separately, Robert W. Baird raised their price target on shares of Medpace from $354.00 to $362.00 and gave the company a "neutral" rating in a report on Monday, January 27th. Seven equities research analysts have rated the stock with a hold rating and five have given a buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus target price of $381.44.

Medpace Profile

Medpace Holdings, Inc engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance.